Get the Stockscreener App
3.97
0.25%
0.01
After Hours:
4.04
0.07
+1.76%
Bioaffinity Technologies Inc stock is traded at $3.97, with a volume of 13.09M.
It is up +0.25% in the last 24 hours and up +264.22% over the past month.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.
See More
Previous Close:
$3.96
Open:
$4.595
24h Volume:
13.09M
Relative Volume:
1.71
Market Cap:
$17.86M
Revenue:
$6.78M
Net Income/Loss:
$-14.74M
P/E Ratio:
-0.2462
EPS:
-16.1258
Net Cash Flow:
$-8.51M
1W Performance:
+63.37%
1M Performance:
+264.22%
6M Performance:
+16.42%
1Y Performance:
-54.05%
1-Day Range:
$3.795
$4.9699
1-Week Range:
$2.30
$5.38
52-Week Range:
$0.693
$46.53
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
Name
Bioaffinity Technologies Inc
Sector
Industry
Phone
210-698-5334
Address
3300 NACOGDOCHES ROAD, SAN ANTONIO
Compare BIAF vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
3.97 | 17.81M | 6.78M | -14.74M | -8.51M | -16.13 |
TMO
Thermo Fisher Scientific Inc
|
490.77 | 182.14B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
187.15 | 134.43B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
575.72 | 45.40B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
112.98 | 32.27B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
302.32 | 29.62B | 3.17B | 642.63M | 516.49M | 10.77 |
Bioaffinity Technologies Inc Stock (BIAF) Latest News
bioAffinity Launches Virtual Roundtables on CyPath Lung Adoption - TipRanks
bioAffinity Technologies (BIAF) plans CyPath Lung webinar showcasing real-world clinical use - Stock Titan
BioAffinity Technologies stock soars 120% on CyPath lung sales growth - MSN
BioAffinity’s CyPath Lung Tests Signal Powerful Growth for 2026 - timothysykes.com
BioAffinity Technologies Reports Record Growth Amid Challenges - StocksToTrade
What's Going On With bioAffinity Technologies Stock Wednesday? - Benzinga
bioAffinity Technologies Shows Significant Growth in Diagnostic Development - timothysykes.com
bioAffinity Technologies to Host Live Virtual Physician Roundtable on Integrating CyPath® Lung into Pulmonary Practice - Business Wire
BioAffinity Technologies stock cools off after strong Friday rallyhere's why - MSN
bioAffinity Technologies soars Monday as non-invasive lung cancer tech gains traction - Mugglehead Investment Magazine
Promising Biotech Stocks To ConsiderMarch 23rd - MarketBeat
bioAffinity Technologies shares soar as investors react to upbeat CyPath Lung growth update and 2026 outlook - Quiver Quantitative
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
If You Invested $1,000 in bioAffinity Tech (BIAF) - Stock Titan
What's going on with bioAffinity stock Thursday? - MSN
Big Money Moves: Is bioAffinity Technologies Inc affected by consumer sentimentRate Hike & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Why did BIAF stock surge 20% in pre-market today? - MSN
Top QCM Diagnostics (QCMD) Competitors 2026 - MarketBeat
BIAF Rises Amid Expansions and Innovations - timothysykes.com
Why is bioAffinity Technologies stock surging Tuesday? - MSN
Jobs Data: Can bioAffinity Technologies Inc lead its sector in growthPortfolio Growth Summary & Entry Point Confirmation Alerts - baoquankhu1.vn
What's Going On With bioAffinity Stock Thursday? - Benzinga
BioAffinity Technologies posts 2025 results as CyPath lung testing growth accelerates - MSN
bioAffinity Showcases CyPath Lung Case Study in Diagnostics - TipRanks
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
CyPath Lung case study at bioAffinity (NASDAQ: BIAF) shows noninvasive option - Stock Titan
New Case Study: bioAffinity Technologies’ CyPath® Lung Provides Actionable Results and Helps Patient Avoid Costly, Invasive Procedures - Business Wire
Top Biotech Stocks To Follow TodayMarch 17th - MarketBeat
Crude Oil Gains Around 2%; Elbit Systems Shares Jump On Upbeat Earnings - Benzinga
BioAffinity Technologies Eyes Further Expansion Amid Growing Market Demand - StocksToTrade
Why Is bioAffinity Technologies Stock Surging Tuesday? - Benzinga
CyPath Lung Diagnostic Tool Spurs bioAffinity Technologies’ Growth - timothysykes.com
Can bioAffinity Technologies Inc Equity Warrant weather a recessionDip Buying & Reliable Price Breakout Signals - baoquankhu1.vn
BioAffinity Technologies, Inc. Releases New Clinical Case Study That Highlights the Benefit of Adding CyPath Lung - marketscreener.com
bioAffinity (NASDAQ: BIAF) proxy adds reverse split and major share authorizations - Stock Titan
bioAffinity Technologies 2024 Annual Report: Business Overview, Clinical Trial Updates, and Key Risks for Diagnostic and Therapeutic Product Development - Minichart
bioAffinity Technologies Stock Cools Off After Strong Friday RallyHere's Why - Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
bioAffinity Technologies 10-K: Revenue $6.16M, EPS $(8.66) - TradingView
Form DEF 14A bioAffinity Technologies For: 16 March - Investing.com
Best Small Cap Stocks To Add to Your WatchlistMarch 15th - MarketBeat
Promising Biotech Stocks To Add to Your WatchlistMarch 15th - MarketBeat
Crude Oil Gains Over 1%; VEON Shares Spike Higher - Sahm
12 Health Care Stocks Moving In Friday's Intraday Session - Sahm
12 Health Care Stocks Moving In Friday's Pre-Market Session - Sahm
Promising Small Cap Stocks To ConsiderMarch 14th - MarketBeat
Biotech Stocks To Watch NowMarch 14th - MarketBeat
BioAffinity Technologies Projects Strong Growth Amid Market Fluctuations - timothysykes.com
symbol__ Stock Quote Price and Forecast - CNN
bioAffinity Technologies reports 2025 financial results By Investing.com - Investing.com India
Small Cap Stocks To Follow TodayMarch 13th - MarketBeat
Bioaffinity Technologies Inc Stock (BIAF) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.19%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):